Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02947737 · ClinicalTrials.gov registry record · NA
Amniotic Membrane for Donor Site Healing
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02947737: Completed NA study, sponsored by Emory University.
NCT02947737 is a NA study that has completed, run by Emory University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02947737, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of applying amniotic membrane dressings compared to gentamicin and xeroform dressings to donor sites for skin grafts. This study will enroll ten participants who undergoing a split thickness skin graft procedure with two or more donor sites. The amniotic membrane will be applied to one donor site and a dressing of xeroform and gentamicin will be applied to another other donor site. Each participant will receive both types of dressing and will serve as their own control. Postoperative follow up will follow standard of care, regardless of the dressing type. Dressings will be removed on postoperative day 4 and participants will return to be re-examined one week after being discharged from the hospital.
Primary Outcome
Participants will report their pain level for each donor site as a numeric score from 1 to 10.
Interventions
- OTHER Amniotic membrane dressing
- OTHER Gentamicin and xeroform dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
What the finished NCT02947737 record still lists
NCT02947737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Amniotic membrane dressing is the first listed.
NCT02947737 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02947737 about?
NCT02947737 is a clinical study titled "Amniotic Membrane for Donor Site Healing". The purpose of this study is to compare the effectiveness of applying amniotic membrane dressings compared to gentamicin and xeroform dressings to donor sites for skin grafts. This study will enroll ten participants who undergoing a split thickness skin graft procedure with two or more donor sites. ...
What is the current status of trial NCT02947737?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-02-01. Estimated completion is 2017-08-31.
What interventions are being tested in trial NCT02947737?
The interventions under investigation include: Amniotic membrane dressing (OTHER), Gentamicin and xeroform dressing (OTHER).
Who is sponsoring clinical trial NCT02947737?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02947737's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI